<?xml version="1.0" encoding="UTF-8"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcq="http://purl.org/dc/terms/"><records count="1" morepages="false" start="1" end="1"><record rownumber="1"><dc:product_type>Conference Paper</dc:product_type><dc:title>SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE</dc:title><dc:creator>Yeoheung Yun</dc:creator><dc:corporate_author/><dc:editor/><dc:description>Human induced pluripotent stem cell (hiPSC)-derived brain 
organoids can recapitulate the complex cytoarchitecture of the brain 
as well as the genetic and epigenetic footprint of human brain 
development. Although the brain organoids are able to mimic the 
structures and functions of brain in vitro, the 3D models have 
difficulty in integrating a complex vascular network that can provide 
the interaction with organoids. Here we report on a microfluidic#2;based three-dimensional, vascularized cortical organoid tissue 
construct consisting of 1) a perfused micro-vessel against an 
extracellular matrix (ECM), dynamic flow and membrane-free 
culture of the endothelial layer, 2) a sprouted vascular network using 
a combination of angiogenic factors, and 3) a vascularized hiPSC#2;derived cortical organoid. We report on an optimization of 
density/stiffness of ECM to induce angiogenic sprouting and effect 
of angiogenic factors to trigger robust, rapid, and directional 
angiogenesis for concentration-driven and repetitive sprout 
formation. Vascularized network in the microfluidic device was 
further characterized in terms of morphology, directional alignment 
under perfusion, lumen formation, and permeability. HiPSC#2;derived cortical organoid was generated, placed, and integrated into 
a vascularized network in the vascularized microfluidic device. We 
investigate how vascularized micro-vessels interact with cortical 
organoid. This paper further demonstrates the potential utility of a 
membrane-free vascularized cortical organoid in perfusion used to 
model Alzheimer’s disease and for toxicity screening of nerve 
agents.</dc:description><dc:publisher/><dc:date>2022-08-24</dc:date><dc:nsf_par_id>10430436</dc:nsf_par_id><dc:journal_name>Vascularized Cortical Organoid Microphysiological  System To Model Alzheimer’s Disease</dc:journal_name><dc:journal_volume/><dc:journal_issue/><dc:page_range_or_elocation/><dc:issn/><dc:isbn/><dc:doi>https://doi.org/</dc:doi><dcq:identifierAwardId>2100987</dcq:identifierAwardId><dc:subject/><dc:version_number/><dc:location/><dc:rights/><dc:institution/><dc:sponsoring_org>National Science Foundation</dc:sponsoring_org></record></records></rdf:RDF>